System and method for monitoring the health of dialysis patients

1. A method comprising:

obtaining multiple dialysate or urine samples from a dialysis patient;

providing a Raman spectrum from each of the multiple samples of the patient;

providing one or more reference Raman spectrum;

detecting a molecular fingerprint of four or more analytes relative to one another in each of the Raman spectra, wherein four or more of the analytes are chosen from creatinine, uric acid, uric acid based compounds, interleukin-8, bilirubin, a1-anti-trypsin, arginine, homoarginine, urea, urea-based compounds, urea nitrogen based compounds, ammonium-based compounds, nitrogen-based compounds, vitamins, vitamin C, vitamin B12, folic acid, zinc, amino acids, proteins, nucleic acids, pharmaceutical compounds, 2-heptanal, 2-hexenal, 2-nonenal, 4-decenal, 4-HO-decenal, 4-HO-hexenal, 4-HO-nonenal, 4-HO-octenal, 4-pyrididone-3-carboxy-1-β-D-ribonucleoside, 8-Hydroxy-2’deoxyguanosine, α-Keto-δ-guanidinovlaeric acid, antranilic acid, argininic acid, dimethylarginine, cysteine, decanal, dimethylamine, ethylamine, guanidine, guanidinoacetic acid, guanidine succinic acid, hepatanal, hexanal, hypoxanthine, malondialdehyde, methylguanidine, monomethylamine, neopterine, nicotinamide, N-methyl-2-pyridone-5-carboxamide, N-methyl-4-pyridone-3-carboxamide, nonanal, noradrenaline, oxalate, phenylacetic acid, dimethylarginine, trimethylamine, trimethylamine-N-oxide, 3-carboxy-4-methyl-5-propyl-2-furan-propanoic acid, acrolein, carboxymethyllysine, dihydroxyphenylalanine, hippuric acid, homocysteine, indicant, indole-3-acetic acid, indoxyl sulfate, indoxyl-β-D-glucoronide, kynurenic acid, p-cresyl sulfate, pentosidine, phenol, putrescine, permidine, thiocyanate, α1-acid glycoprotein, α1-microglobulin, β-trace protein, β2-microglobulin, adiponectin, angiogenin, calcitonin, complement factor D, cystatin C, fibroblast growth factor-23, glutathione, reduced glutathione, insulin-like growth factor 1 (IGF-1), interleukin 6 (IL-6), interleukin 8 (IL-8), interleukin 10 (IL-10), leptin, hemoglobin, myoglobin, osteocalcin, parathyroid hormone (PTH), prolactin, resistin, retinal binding protein, soluble intracellular adhesion molecule-1, TNF-α, and vascular endothelial growth factor;

treating the patient according to a dialysis prescription; and

modifying the dialysis prescription to provide a dynamic dialysis prescription based on analyte kinetics of the four or more analytes relative to one another represented from the multiple samples of the patient and the reference, wherein the modifying comprises one or more of:

increasing or decreasing dialysis treatment time;

increasing or decreasing the rate of blood flow through a dialyzer; or

increasing or decreasing the frequency of dialysis treatments.

2. The method of claim 1 , wherein the reference is a second patient sample from the dialysis patient and further comprising obtaining a third patient sample from the dialysis patient and detecting a molecular fingerprint of four or more analytes in the third patient sample.

3. The method of claim 1 , wherein a pattern presented by the relative presence of four or more of the analytes is representative of a particular treatment outcome characteristic or disease state.

4. The method of claim 1 , wherein the molecular fingerprint of four or more analytes within the patient Raman spectrum is detected by selecting one or more wavelength(s) of interest.

5. The method of claim 4 , wherein the one or more wavelength(s) is selected from about 930 cm −1 , about 1000 cm −1 , about 1040 cm −1 , and/or about 1070 cm −1 .